Skip to main content
Clinical Trials/ACTRN12624000590561
ACTRN12624000590561CompletedUnknown

Randomised Controlled Trial on 360° Phototherapy versus Single Surface LED Phototherapy in Neonatal Hyperbilirubinemia

niversiti Sains Malaysia0 sites40 target enrollmentStarted: May 9, 2024Last updated:
Conditions

Trial Snapshot

Phase
Unknown
Status
Completed
Sponsor
Enrollment
40

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Open (masking not used)

Eligibility Criteria

Ages
o limit to 7 Days (—)
Sex
All

Inclusion Criteria

  • The study will include all term neonates who are born at 35 weeks of age or more, and age less than or equal to 7 days, with unconjugated hyperbilirubinemia, requiring intensive phototherapy following the Malaysian guideline of neonatal jaundice. The neonates weight must be 2 kg or more and has not received any phototherapy before.

Exclusion Criteria

  • Neonates whose serum bilirubin level is above the exchange transfusion level following the Malaysian guideline of neonatal jaundice will not be included in the study. Other exclusion criterias include direct hyperbilirubinemia of >15%, neonates with congenital abnormalities or inborn error of metabolism and neonates who required intensive care.

Investigators

Sponsor
niversiti Sains Malaysia

Similar Trials